Clinical Trial Update: SYNERGY China: Assess SYNERGY Stent in China [NA]

View source ↗

Summary

A completed clinical trial update for the SYNERGY stent in China with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases

Drugs mentioned

• SYNERGY Stent (Everolimus-eluting stent)

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Cardiovascular Diseases | NA | Status: COMPLETED | Results posted: 2016-01-18